Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimmune Response to Alcohol PET Study
NCT04251221Phase 1Completed
- Sponsor
- Yale University
- Start
- Jun 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ethanol in alcohol use disorder (AUD), sponsored by Yale University. Primary endpoint: Percent Change in [11C]PBR28 Distribution Volume. Started Jun 2019; status: completed.
02
Drugs
ethanol
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04251221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04251221.